Should Percutaneous Coronary Intervention Be Considered for Left Main Coronary Artery Disease?: Insights From a Bayesian Reanalysis of the EXCEL Trial

Affiliations

Comment

Sanjay Kaul. JAMA Intern Med. 2020.

. 2020 Jul 1;180(7):1002-1003.

doi: 10.1001/jamainternmed.2020.1644.

¹ Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California.

No abstract available

Comment on

Characteristics of Contemporary Randomized Clinical Trials and Their Association With the Trial Funding Source in Invasive Cardiovascular Interventions.
Gaudino M, Hameed I, Rahouma M, Khan FM, Tam DY, Biondi-Zoccai G, Demetres M, Charlson ME, Ruel M, Crea F, Falk V, Girardi LN, Fremes S, Chikwe J. Gaudino M, et al. JAMA Intern Med. 2020 Jul 1;180(7):993-1001. doi: 10.1001/jamainternmed.2020.1670. JAMA Intern Med. 2020. PMID: 32478821 Free PMC article. Review.
Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization.
Brophy JM. Brophy JM. JAMA Intern Med. 2020 Jul 1;180(7):986-992. doi: 10.1001/jamainternmed.2020.1647. JAMA Intern Med. 2020. PMID: 32478838 Free PMC article.